Loading...
 
Mediterr J Rheumatol 2018;29(3):118-9
Mediterranean Journal of Rheumatology September 2018 Highlights
Authors Information

Department of Rheumatology and Clinical Immunology, University General Hospital of Larissa, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece

References
  1. Liaskos C, Marou E, Simopoulou T, Gkoutzourelas A, Barmakoudi M, Efthymiou G, et al. Multiparametric autoantibody profiling of patients with systemic sclerosis in Greece. Mediterr J Rheumatol 2018;29(3):120-6.
  2. Ziaragkali S, Kotsalidou A, Trakos N. Dry Eye Disease in Routine Rheumatology Practice. Mediterr J Rheumatol 2018;29(3):127-39.
  3. Ahmed S, Pattanaik S S, Rai M K, Nath A, Agarwal V. Interstitial lung disease in Systemic sclerosis: insights into pathogenesis and evolving therapies. Mediterr J Rheumatol 2018;29(3):140-7.
  4. Christoforidou A, Galanopoulos N. Diffuse connective tissue disorders in HIV-infected patients. Mediterr J Rheumatol 2018;29(3):148-55.
  5. Pratsidou-Gertsi P. Transition of pediatric patients with an Auto-inflammatory Disease: an alternative version of Daedaulus and Icarus myth. Mediterr J Rheumatol 2018;29(3):156-62.
  6. Panagopoulos P, Katsifis G. Secondary hemophagocytic lymphohistiocytosis in a patient with rheumatoid arthritis and vasculitis: a case report and review of the literature, Mediterr J Rheumatol 2018;29(3):163-9.
  7. Marketos N, Bournazos I, Ioakimidis D. Canakinumab for refractory RA: a case report. Mediterr J Rheumatol 2018;29(3):170-2.
  8. Agryropoulou O, Protogerou A, Argyris A, Tzioufas A G, Vlachoyiannopoulos P. Extensive phenotyping of vascular damage in non-infectious primary vasculitides with the use of non-invasive vascular biomarkers: prevalence, pathogenesis and response to treatment. Mediterr J Rheumatol 2018;29(3):173-7.
  9. Daoussis D, Kordas P. ACTH vs betamethasone for the treatment of acute gout in hospitalized patients: A randomized, open label, comparative study. Mediterr J Rheumatol 2018;29(3):178-81.